Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inspyr Therapeutics Inc (NSPX)

Inspyr Therapeutics Inc (NSPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,467
  • Shares Outstanding, K 543,152
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,300 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -16.57
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/19/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0018 +50.00%
on 10/01/21
0.0051 -47.06%
on 10/05/21
+0.0005 (+22.73%)
since 09/10/21
3-Month
0.0010 +170.00%
on 08/26/21
0.0088 -69.32%
on 08/02/21
-0.0039 (-59.09%)
since 07/09/21
52-Week
0.0010 +170.00%
on 08/26/21
0.0718 -96.24%
on 10/13/20
-0.0179 (-86.89%)
since 10/09/20

Most Recent Stories

More News
Inspyr Therapeutics Reports Financial Results and Business Update For Full Year 2020

- Implements new corporate strategy to focus on precision therapeutics for the treatment of cancer - Strengthens pipeline by acquiring a proprietary portfolio of novel adenosine immuno-modulator compounds...

NSPX : 0.0027 (-18.18%)
Inspyr Therapeutics Further Strengthens Global Intellectual Property

WESTLAKE VILLAGE, CA / ACCESSWIRE / February 18, 2021 / Inspyr Therapeutics, Inc. (OTC PINK:NSPX), a pharmaceutical company focused on the research and development of novel targeted precision therapeutics...

NSPX : 0.0027 (-18.18%)

Business Summary

Inspyr Therapeutics, Inc. is a biotechnology company which focuses on the discovery and development of prodrug cancer therapeutics for the treatment of solid tumors, including liver, brain, prostate, and other cancers primarily in the United States. Its product candidates include Mipsagargin, G-115,...

See More

Key Turning Points

3rd Resistance Point 0.0040
2nd Resistance Point 0.0037
1st Resistance Point 0.0032
Last Price 0.0027
1st Support Level 0.0024
2nd Support Level 0.0021
3rd Support Level 0.0016

See More

52-Week High 0.0718
Fibonacci 61.8% 0.0448
Fibonacci 50% 0.0364
Fibonacci 38.2% 0.0280
Last Price 0.0027
52-Week Low 0.0010

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar